Showing 741 - 760 results of 21,342 for search '(( significant ((i decrease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.56s Refine Results
  1. 741
  2. 742
  3. 743

    Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i> by Vidya G. Bettada (22208808)

    Published 2025
    “…Very minimal cytotoxic effect (<10% cell death) was observed at the highest concentration of vitamin D3 tested (i.e., 400µM). 1C. Liver cancer cell line Hep 3B exposed to increasing concentrations of vitamin D3 showed a dose-dependent increase in cytotoxic effect beginning from 31.25µM; 1D. …”
  4. 744
  5. 745

    shCCND1 plasmid. by Dequan Wang (6007007)

    Published 2024
    Subjects:
  6. 746

    Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

    Published 2024
    “…<i>n</i> = 100 in D and E, and 20 in F. Underlying data can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002876#pbio.3002876.s016" target="_blank">S1 Data</a>.…”
  7. 747
  8. 748
  9. 749

    A total of 700 DEGs. by Wei He (131453)

    Published 2025
    Subjects:
  10. 750
  11. 751
  12. 752
  13. 753
  14. 754
  15. 755

    Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

    Published 2024
    “…For panel B, error bars represent the standard error of the mean (<i>n</i> = 25), and statistical significance was analyzed by one-way ANOVA with a Tukey post hoc test (*<i>p</i> < 0.05 and **<i>p</i> < 0.01). …”
  16. 756
  17. 757

    Fig 10 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
  18. 758

    Fig 4 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
  19. 759

    Fig 9 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
  20. 760

    Fig 6 - by Farshid Maleki (20521649)

    Published 2025
    Subjects: